Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

Figure 2

Intestinal permeability in patients with or without chemotherapy induced diarrhea. Intestinal permeability in patients who suffered from chemotherapy induced diarrhea, CTD(+), and those who did not, CTD(−). Small intestinal permeability was probed by measuring the urinary cumulative 5-hour amount of lactulose (Lactulose% = percentage of ingested lactulose), mannitol (Mannitol%) and the Lactulose to Mannitol ratio. Data are reported as medians and the range and analyzed with Wilcoxon matched-pairs signed rank test.

Back to article page